Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 547 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Extracorporeal Photopheresis And Mogamulizumab For The Treatment Of Erythrodermic Cutaneous T Cell Lymphoma

    Scottsdale/Phoenix, AZ

  3. Study Of The Theranostic Pair RYZ811 (Diagnostic) And RYZ801 (Therapeutic) To Identify And Treat Subjects With GPC3+ Unresectable HCC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. First in Human Study of TORL-4-500 in Participants With Advanced Cancer

    Scottsdale/Phoenix, AZ

  5. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC)

    Rochester, MN

  6. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  7. Confirmatory Study of Topical HyBryte™ Vs. Placebo for the Treatment of CTCL (FLASH2)

    Scottsdale/Phoenix, AZ

  8. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  9. Decitabine In Combination With Standard Of Care Therapy For The Treatment Of Surgically Resectable HPV-Negative Head And Neck Cancer

    Jacksonville, FL

  10. Zanzalintinib Versus Everolimus In Participants With Locally Advanced Or Metastatic Neuroendocrine Tumors

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer